CervoMed Inc. Litigation Settlement, Expense
CervoMed Inc. (CRVO) reported Litigation Settlement, Expense of $2.50 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2018-04-02
- CervoMed Inc. litigation settlement, expense for the quarter ending 2016-12-31 was $0.00.
- CervoMed Inc. litigation settlement, expense for fiscal 2016 was $2.50M.
- CervoMed Inc. litigation settlement, expense for fiscal 2015 was $0.00.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $2.50M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $2.50M 10-Q · filed 2017-11-13 | ||
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |